Patrick Vermersch

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 18

Top Venues

Neurology and therapy

Neurology(R) neuroimmunology & neuroinflammation

Neurology

Advances in therapy

University of Lille

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Lille

France

Professor :: Neurology

Publications

Jonathan Ciron, Bertrand Bourre, Giovanni Castelnovo, Anne Marie Guennoc, Jérôme De Sèze, Ali Frederic Ben-Amor, Carine Savarin, Patrick Vermersch
Holistic, Long-Term Management of People with Relapsing Multiple Sclerosis with Cladribine Tablets: Expert Opinion from France. Neurology and therapy 13 (3) (2024)
Giancarlo Comi, Gloria Dalla Costa, Bruno Stankoff, Hans-Peter Hartung, Per Soelberg Sørensen, Patrick Vermersch, Letizia Leocani
Assessing disease progression and treatment response in progressive multiple sclerosis. Nature reviews. Neurology (2024)
Jonathan Ciron, Bertrand Bourre, Giovanni Castelnovo, Anne Marie Guennoc, Jérôme De Sèze, Ali Frederic Ben-Amor, Carine Savarin, Patrick Vermersch
Holistic, Long-Term Management of People with Relapsing Multiple Sclerosis with Cladribine Tablets: Expert Opinion from France. Neurology and therapy 13 (3) (2024)
Jonathan Ciron, Bertrand Bourre, Giovanni Castelnovo, Anne Marie Guennoc, Jérôme De Sèze, Ali Frederic Ben-Amor, Carine Savarin, Patrick Vermersch
Holistic, Long-Term Management of People with Relapsing Multiple Sclerosis with Cladribine Tablets: Expert Opinion from France. Neurology and therapy 13 (3) (2024)
Jonathan Ciron, Bertrand Bourre, Giovanni Castelnovo, Anne Marie Guennoc, Jérôme De Sèze, Ali Frederic Ben-Amor, Carine Savarin, Patrick Vermersch
Holistic, Long-Term Management of People with Relapsing Multiple Sclerosis with Cladribine Tablets: Expert Opinion from France. Neurology and therapy (2024)
Jonathan Ciron, Bertrand Bourre, Giovanni Castelnovo, Anne Marie Guennoc, Jérôme De Sèze, Ali Frederic Ben-Amor, Carine Savarin, Patrick Vermersch
Holistic, Long-Term Management of People with Relapsing Multiple Sclerosis with Cladribine Tablets: Expert Opinion from France. Neurology and therapy 13 (3) (2024)
Celia Oreja-Guevara, Stanca Potra, Birgit Bauer, Diego Centonze, Maria-Paz Giambastiani, Gavin Giovannoni, Jϋrg Kesselring, Dawn Wendy Langdon, Sarah A Morrow, Jocelyne Nouvet-Gire, Maija Pontaga, Peter Rieckmann, Sven Schippling, Nektaria Alexandri, Jane Shanahan, Heidi Thompson, Pieter van Galen, Patrick Vermersch, David Yeandle
Summary of Research: Collaboration Between Healthcare Professionals and People with Multiple Sclerosis to Develop Communication Tools to Improve the Standard of Multiple Sclerosis Care. Advances in therapy (2023)
Nicola De Stefano, Frederik Barkhof, Xavier Montalban, Anat Achiron, Tobias Derfuss, Andrew Chan, Suzanne Hodgkinson, Alexandre Prat, Letizia Leocani, Klaus Schmierer, Finn Sellebjerg, Patrick Vermersch, Heinz Wiendl, Birgit Keller, Sanjeev Roy, null null
Early Reduction of MRI Activity During 6 Months of Treatment With Cladribine Tablets for Highly Active Relapsing Multiple Sclerosis: MAGNIFY-MS. Neurology(R) neuroimmunology & neuroinflammation 9 (4) (2022)
Nicolas Vamour, Pierre-Luc Dequirez, Denis Seguier, Patrick Vermersch, Stefan De Wachter, Xavier Biardeau
Early interventions to prevent lower urinary tract dysfunction after spinal cord injury: a systematic review. Spinal cord 60 (5) (2022)
Bénédicte Oxombre, Fahima Madouri, Anne-Sophie Journé, Séverine Ravez, Eloise Woitrain, Pascal Odou, Nathalie Duhal, Sandro Ninni, David Montaigne, Nadira Delhem, Patrick Vermersch, Patricia Melnyk
Safe and Efficient Sigma1 Ligand: A Potential Drug Candidate for Multiple Sclerosis. International journal of molecular sciences 23 (19) (2022)
Jerome De Sèze, Laurent Suchet, Claude Mekies, Eric Manchon, Pierre Labauge, Anne-Marie Guennoc, Gilles Defer, Pierre Clavelou, Giovanni Castelnovo, Bertrand Bourre, Caroline Bensa-Koscher, Abdullatif Al Khedr, Julie Le Mao, Lauriane Villemur, Stephane Bouée, Laura Luciani, Patrick Vermersch
The Place of Immune Reconstitution Therapy in the Management of Relapsing Multiple Sclerosis in France: An Expert Consensus. Neurology and therapy (2022)
Jean-Guillaume Letarouilly, Patrick Vermersch, René Marc Flipo
Therapeutic consequences in patients with both inflammatory rheumatic diseases and multiple sclerosis. Rheumatology (Oxford, England) (2022)
Bruno Brochet, Pierre Clavelou, Gilles Defer, Jérôme De Seze, Céline Louapre, Eloi Magnin, Aurélie Ruet, Catherine Thomas-Anterion, Patrick Vermersch
Cognitive Impairment in Secondary Progressive Multiple Sclerosis: Effect of Disease Duration, Age, and Progressive Phenotype. Brain sciences 12 (2) (2022)
Gavin Giovannoni, Giancarlo Comi, Kottil Rammohan, Peter Rieckmann, Fernando Dangond, Birgit Keller, Dominic Jack, Patrick Vermersch
Long-Term Disease Stability Assessed by the Expanded Disability Status Scale in Patients Treated with Cladribine Tablets 3.5 mg/kg for Relapsing Multiple Sclerosis: An Exploratory Post Hoc Analysis of the CLARITY and CLARITY Extension Studies. Advances in therapy 38 (9) (2021)
Tjalf Ziemssen, Gavin Giovannoni, Enrique Alvarez, Virender Bhan, Carrie M Hersh, Olaf Hoffmann, Celia Oreja-Guevara, Rene R Robles-Cedeño, Maria Trojano, Patrick Vermersch, Maria Pamela Dobay, Mudeer Khwaja, Bianca Stadler, Benedict Rauser, Thomas Hach, Daniela Piani-Meier, Jason Burton
Multiple Sclerosis Progression Discussion Tool Usability and Usefulness in Clinical Practice: Cross-sectional, Web-Based Survey. Journal of medical Internet research 23 (10) (2021)
Nicolás Fissolo, Beatrice Pignolet, Jordi Rio, Patrick Vermersch, Aurélie Ruet, Jerome deSèze, Pierre Labauge, Sandra Vukusic, Caroline Papeix, Laurent Martinez-Almoyna, Ayman Tourbah, Pierre Clavelou, Thibault Moreau, Jean Pelletier, Christine Lebrun-Frénay, Bertrand Bourre, Gilles Defer, Xavier Montalban, David Brassat, Manuel Comabella Lopez
Serum Neurofilament Levels and PML Risk in Patients With Multiple Sclerosis Treated With Natalizumab. Neurology(R) neuroimmunology & neuroinflammation 8 (4) (2021)
Jean-Baptiste Davion, Renaud Lopes, Elodie Drumez, Julien Labreuche, Nawal Hadhoum, Julien Lannoy, Patrick Vermersch, Jean-Pierre Pruvo, Xavier Leclerc, Hélène Zéphir, Olivier Outteryck
Asymptomatic optic nerve lesions: An underestimated cause of silent retinal atrophy in MS. Neurology 94 (23) (2020)
Ralph H B Benedict, Davorka Tomic, Bruce A Cree, Robert Fox, Gavin Giovannoni, Amit Bar-Or, Ralf Gold, Patrick Vermersch, Harald Pohlmann, Ian Wright, Göril Karlsson, Frank Dahlke, Christian Wolf, Ludwig Kappos
Siponimod and Cognition in Secondary Progressive Multiple Sclerosis: EXPAND Secondary Analyses. Neurology 96 (3) (2020)

Patrick Vermersch.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Patrick Vermersch